Results 131 to 140 of about 53,857 (243)

Pseudotumor Cerebri Syndrome and Essential Thrombocythemia: A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 6, June 2026.
ABSTRACT Pseudotumor cerebri syndrome (PTCS) is characterized by elevated intracranial pressure in the absence of intracranial mass lesions, structural abnormalities, or infectious conditions. Although the exact pathogenesis of PTCS remains largely elusive, it is increasingly recognized as a multifactorial condition.
Fang‐Tzu Chang   +2 more
wiley   +1 more source

Ultrasound-activated and P-selectin-targeted liposomes overcome biofilm barriers for surgical site infections therapy. [PDF]

open access: yesJ Nanobiotechnology
Liu X   +10 more
europepmc   +1 more source

Landscape of Immune Remodeling and NAP1L1‐Driven Epithelial Reprogramming in Gastric Cancer Metastasis

open access: yesChronic Diseases and Translational Medicine, Volume 12, Issue 2, Page 126-138, June 2026.
High‐resolution single‐cell atlas of normal gastric tissue, primary gastric cancer, and metastatic lesions. (A) Schematic diagram of experimental design. (B) Bar plot for qualified cell numbers in each lesion. (C) Cells annotation by canon markers for all cells. (D) Bubble chart for canon marker genes for each cell subtype.
Min Sun   +3 more
wiley   +1 more source

Adjunctive Methylprednisolone After Thrombectomy: A Secondary Analysis Stratified by Admission White Blood Cell Count

open access: yesCNS Neuroscience &Therapeutics, Volume 32, Issue 6, June 2026.
Admission WBC identified who benefited from adjunctive methylprednisolone after thrombectomy. Improved 90‐day function and lower mortality/pneumonia occurred only with WBC ≥ 10 × 109/L, supporting WBC‐guided corticosteroid targeting. ABSTRACT Background Leukocyte‐driven inflammation may contribute to reperfusion–outcome mismatch after thrombectomy.
Chengsong Yue   +9 more
wiley   +1 more source

Orexin B Reduces Cerebral Aneurysms Through Inhibition of SP‐1

open access: yesCNS Neuroscience &Therapeutics, Volume 32, Issue 6, June 2026.
Orexin B/OX2R signaling attenuates cerebral aneurysm formation by suppressing SP‐1‐mediated inflammation, macrophage infiltration, and endothelial adhesion, with OX2R knockdown abolishing these protective effects. The study highlights Orexin B as a therapeutic candidate targeting vascular inflammation and remodeling in aneurysms.
Lei Chen   +4 more
wiley   +1 more source

Correction to: Associations of sphingosine‑1‑phosphate with soluble P‑selectin and adverse clinical outcome in patients with cerebral ischemia with and without acetylsalicylic acid treatment. [PDF]

open access: yesNaunyn Schmiedebergs Arch Pharmacol
Gloyer NO   +10 more
europepmc   +1 more source

Extracellular Vesicles as Drivers of Lung Endothelial Dysfunction in ARDS: Mechanisms and Therapeutic Opportunities

open access: yesComprehensive Physiology, Volume 16, Issue 3, June 2026.
This review summarizes how extracellular vesicles from diverse pulmonary and extrapulmonary sources contribute to endothelial dysfunction in ARDS and evaluates emerging endothelial‐targeted therapies for their potential to mitigate EV‐mediated pathogenic mechanisms.
Mohammed Yaman Al Matni   +3 more
wiley   +1 more source

Increasing Soluble P-Selectin Levels Predict Higher Peripheral Atherosclerotic Plaque Progression. [PDF]

open access: yesJ Clin Med, 2023
Sommer P   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy